Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear CBS member, This email concerns nominations for positions on the Board of Directors and proposals to host the 2026 Annual Meeting...

As part of its legacy strategy, the NanoMedicines Innovation Network NMIN is creating an online database of Canadian nanomedicines researchers and the areas of expertise represented within their labs...

Dear Trainees, Drs. Marcelo Munoz and Emilio Alarcon will facilitate a workshop on Peptide Synthesis and Applications in Regenerative Medicine at the University of Ottawa Heart Institute from August 14th to 17th, 2023...

Dear Members, The annual conference of the International Society of Biofabrication ISBF is being held this September 17-20 in Saskatoon, Saskatchewan...

Breast cancer metastasis to bone is associated with poor patient prognosis as current non-specific therapeutics are administered systemically with deleterious side effects...

Total joint arthroplasty TJA is the most common treatment option for severe arthritis. Typically the bearing design is a metal CoCr component on an ultra-high molecular weight polyethylene UHMWPE counterface...

Critically sized segmental bone defects CSBDs are significant clinical challenges that require grafts for reconstruction...

Recombinant human bone morphogenetic protein 2 BMP bioimplants are used clinically to promote spinal fusion, fracture non-union and bone defect repair...

Hemophilia is a bleeding disorder that affects roughly 1 in 5000 live births. A form of this disease, hemophilia B, is caused by deficiencies of the clotting protein, factor IX FIX , which is part of the coagulation cascade that, when activated by vascular injury, generates fibrin and its crosslinker, factor XIIIa FXIIIa ...